News dal mondo
15
Mag
EU Regulators discuss new pharma legislation, AI, and more
A panel of European regulators answered questions during a town panel discussion at RAPS Euro Convergence 2026 on the implementation of the new EU Pharmaceutical Legislation and the use of artificial intelligence (AI) in regulatory and drug development...[RAPS]
15
Mag
US FDA’s New AI-Informed Inspection Pilot and What It Means for Industry
We have written on this blog about FDA’s modernization agenda from several angles lately—from...
15
Mag
US FDA official details top observations from QMSR inspections
The top observations identified in Form 483 reports from inspections conducted under the recently implemented...
15
Mag
European Commission outlines plans to mobilize EMA to diversify supply chains
he European Commission has adopted a Global Health Resilience Initiative that gives EMA a role in diversifying...
13
Mag
Deal on tackling EU shortages of essential medicines
Prioritise investment in EU manufacturing capacity to increase autonomy “Buy European”...
le ultime news
02 Apr
AIFA - Aggiornamento Tariffe ISTAT dal 1 aprile 2026
02 Apr
AIFA - Per la prima volta i vertici in missione istituzionale in Giappone
27 Mar
EDQM shares guidance on reliance-based and fast-track CEP filings
25 Mar
Testo unico farmaceutica per ridurre la dipendenza estera dai principi attivi
24 Mar
Istat: +20% import da Cina in 2025, farmaceutico decuplicato a 7,7 mld
24 Mar
Farmaceutica italiana: export boom verso gli Usa, ma cresce la dipendenza dalla Cina
20 Mar
Iran, blocco Hormuz su produzione farmaci: 'se dura ci sarà impatto tra 6 mesi'
19 Mar
Nuove norme UE sui farmaci: più incentivi all’innovazione e controllo della disponibilità